EUVIMEDEUVIMED entdecken
Crossref

Allosteric Inhibitors of the SARS-COV-2 Papain-like Protease Domain Induce Proteasomal Degradation of Its Parent Protein NSP3

Peter E Cockram iD, Benjamin T Walters iD, Aaron Lictao, Frances Shanahan, Ingrid E Wertz, Scott A Foster, Joachim Rudolph iD

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.3c00312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2024. Verfasst von Peter E Cockram und 6 weiteren Autor:innen. Beteiligte Einrichtung: Discovery Chemistry, Genentech, South San Francisco, California 94080, United States. Hauptthemen laut MEDLINE: Papain, COVID-19, Coronavirus Papain-Like Proteases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The papain-like protease of SARS-COV-2 is essential for viral replication and pathogenesis. Its location within a much larger multifunctional protein, NSP3, makes it an ideal candidate for a targeted degradation approach capable of eliminating multiple functions with a single-molecule treatment. In this work, we have developed a HiBiT-based cellular model to study NSP3 degradation and used this platform for the discovery of monovalent NSP3 degraders. We present previously unreported degradation activity of published papain-like protease inhibitors. Follow-up exploration of structure-activity relationships and mechanism-of-action studies points to the recruitment of the ubiquitin-proteasome machinery that is solely driven by site occupancy, regardless of molecular features of the ligand. Supported by HDX data, we hypothesize that binding-induced structural changes in NSP3 trigger the recruitment of an E3 ligase and lead to proteasomal degradation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PapainCOVID-19Coronavirus Papain-Like ProteasesHumansViral Nonstructural ProteinsSARS-CoV-2Protease Inhibitors

Substanzen

Papainpapain-like protease, SARS-CoV-2Viral Nonstructural ProteinsProtease InhibitorsCoronavirus Papain-Like Proteases

Autor:innen und Institutionen

  • Discovery Chemistry, Genentech, South San Francisco, California 94080, United States.
  • Discovery Oncology, Genentech, South San Francisco, California 94080, United States.
  • Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California 94080, United States.

ORCID-Profile: Peter E Cockram, Benjamin T Walters, Joachim Rudolph

Zitieren

APA

Cockram, P. E., Walters, B. T., Lictao, A., Shanahan, F., Wertz, I. E., Foster, S. A., & Rudolph, J. (2024). Allosteric Inhibitors of the SARS-COV-2 Papain-like Protease Domain Induce Proteasomal Degradation of Its Parent Protein NSP3. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00312

Vancouver

Cockram PE, Walters BT, Lictao A, Shanahan F, Wertz IE, Foster SA, et al. Allosteric Inhibitors of the SARS-COV-2 Papain-like Protease Domain Induce Proteasomal Degradation of Its Parent Protein NSP3. ACS Chemical Biology. 2024. doi:10.1021/acschembio.3c00312

BibTeX
@article{Cockram2024,
  author = {Cockram, Peter E and Walters, Benjamin T and Lictao, Aaron and Shanahan, Frances and Wertz, Ingrid E and Foster, Scott A and Rudolph, Joachim},
  title = {Allosteric Inhibitors of the SARS-COV-2 Papain-like Protease Domain Induce Proteasomal Degradation of Its Parent Protein NSP3},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.3c00312}
}
Kostenlos starten →